Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

1. Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications.Diagnostics (Basel, Switzerland) · 2022
   Review
2. Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?Cancers · 2021
   Review
3. Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma.Frontiers in medicine · 2021
   Article
4. Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation.Haematologica · 2020
   Article
5. Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia.BMJ open · 2020
   Article
6. Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia.Cell death & disease · 2018
   Article
7. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?International journal of molecular sciences · 2016
   Review
8. Bone Marrow Immunity and Myelodysplasia.Frontiers in oncology · 2016
   Review
9. The inflammatory microenvironment in MDS.Cellular and molecular life sciences : CMLS · 2015
   Review
10. Immunological derangement in hypocellular myelodysplastic syndromes.Translational medicine @ UniSa · 2014
    Article
11. Novel insights into the mechanism of action of lenalidomide.Oncoimmunology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as